Gene expression profiling in the lungs of pigs with different susceptibilities to Glässer's disease

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Wilkinson, Jamie M ^a,c   Sargent, Carole A ^a   Galina Pantoja, Lucina ^b,d   Tucker, Alexander W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PIC North America   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENETIC CODE; GENETIC IDENTIFICATION; GLASSER DISEASE; IMMUNOREGULATION; LUNG; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SIGNAL TRANSDUCTION; SWINE; TISSUE REPAIR; UNINDEXED SEQUENCE; ANIMAL; GENETIC PREDISPOSITION; GENETICS; HAEMOPHILUS INFECTION; HAEMOPHILUS PARASUIS; LUNG DISEASE; PHYSIOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); HAEMOPHILUS PARASUIS; SUIDAE; SUS;

ANIMALS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS PARASUIS; LUNG DISEASES; SWINE;

EID: 77955007892     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-455     Document Type: Article

References (82)

1. Oliveira S, Pijoan C. Haemophilus parasuis: new trends on diagnosis, epidemiology and control. Vet Microbiol 2004, 99(1):1-12. 10.1016/j.vetmic.2003.12.001, 15019107.
2. Kielstein P, Rapp-Gabrielson VJ. Designation of 15 serovars of Haemophilus parasuis on the basis of immunodiffusion using heat-stable antigen extracts. J Clin Microbiol 1992, 30(4):862-865. 265175, 1572971.
3. Oliveira S, Blackall PJ, Pijoan C. Characterization of the diversity of Haemophilus parasuis field isolates by use of serotyping and genotyping. Am J Vet Res 2003, 64(4):435-442. 10.2460/ajvr.2003.64.435, 12693533.
4. Bak H, Riising HJ. Protection of vaccinated pigs against experimental infections with homologous and heterologous Haemophilus parasuis. Vet Rec 2002, 151(17):502-505.
5. Baumann G, Bilkei G. Effect of vaccinating sows and their piglets on the development of Glasser's disease induced by a virulent strain of Haemophilus parasuis serovar 5. Vet Rec 2002, 151(1):18-21.
6. Takahashi K, Naga S, Yagihashi T, Ikehata T, Nakano Y, Senna K, Maruyama T, Murofushi J. A cross-protection experiment in pigs vaccinated with Haemophilus parasuis serovars 2 and 5 bacterins, and evaluation of a bivalent vaccine under laboratory and field conditions. J Vet Med Sci 2001, 63(5):487-491. 10.1292/jvms.63.487, 11411491.
7. Nielsen R. Pathogenicity and immunity studies of Haemophilus parasuis serotypes. Acta Vet Scand 1993, 34(2):193-198.
8. Amano H, Shibata M, Kajio N, Morozumi T. Pathologic observations of pigs intranasally inoculated with serovar 1, 4 and 5 of Haemophilus parasuis using immunoperoxidase method. J Vet Med Sci 1994, 56(4):639-644.
9. Vahle JL, Haynes JS, Andrews JJ. Experimental reproduction of Haemophilus parasuis infection in swine: clinical, bacteriological, and morphologic findings. J Vet Diagn Invest 1995, 7(4):476-480.
10. Oliveira S, Galina L, Blanco I, Canals A, Pijoan C. Naturally-farrowed, artificially-reared pigs as an alternative model for experimental infection by Haemophilus parasuis. Can J Vet Res 2003, 67(2):146-150. 227044, 12760482.
11. Solano-Aguilar GI, Pijoan C, Rapp-Gabrielson V, Collins J, Carvalho LF, Winkelman N. Protective role of maternal antibodies against Haemophilus parasuis infection. Am J Vet Res 1999, 60(1):81-87.
12. Blanco I, Galina-Pantoja L, Oliveira S, Pijoan C, Sanchez C, Canals A. Comparison between Haemophilus parasuis infection in colostrums-deprived and sow-reared piglets. Vet Microbiol 2004, 103(12):21-27. 10.1016/j.vetmic.2004.06.011, 15381262.
13. Pijoan C, Torremorrell M, Solano G. Colonization patterns by the bacterial flora of young pigs. Proc Am Assoc Swine Pract 1997, 463-464.
14. Blanco I, Canals A, Evans G, Mellencamp MA, Cia C, Deeb N, Wang L, Galina-Pantoja L. Differences in susceptibility to Haemophilus parasuis infection in pigs. Can J Vet Res 2008, 72(3):228-235. 2327248, 18505185.
15. Hedegaard J, Skovgaard K, Mortensen S, Sorensen P, Jensen TK, Hornshoj H, Bendixen C, Heegaard PM. Molecular characterisation of the early response in pigs to experimental infection with Actinobacillus pleuropneumoniae using cDNA microarrays. Acta Vet Scand 2007, 49:11. 10.1186/1751-0147-49-11, 1868913, 17466061.
16. Wang Y, Couture OP, Qu L, Uthe JJ, Bearson SM, Kuhar D, Lunney JK, Nettleton D, Dekkers JC, Tuggle CK. Analysis of porcine transcriptional response to Salmonella enterica serovar Choleraesuis suggests novel targets of NFkappaB are activated in the mesenteric lymph node. BMC Genomics 2008, 9:437. 10.1186/1471-2164-9-437, 2570369, 18811943.
17. Chen H, Li C, Fang M, Zhu M, Li X, Zhou R, Li K, Zhao S. Understanding Haemophilus parasuis infection in porcine spleen through a transcriptomics approach. BMC Genomics 2009, 10:64. 10.1186/1471-2164-10-64, 2660370, 19196461.
18. Bates JS, Petry DB, Eudy J, Bough L, Johnson RK. Differential expression in lung and bronchial lymph node of pigs with high and low responses to infection with porcine reproductive and respiratory syndrome virus. J Anim Sci 2008, 86(12):3279-3289. 10.2527/jas.2007-0685, 18641179.
19. Oliveira S, Galina L, Pijoan C. Development of a PCR test to diagnose Haemophilus parasuis infections. J Vet Diagn Invest 2001, 13(6):495-501.
20. Centurion-Lara A, Castro C, Shaffer JM, Van Voorhis WC, Marra CM, Lukehart SA. Detection of Treponema pallidum by a sensitive reverse transcriptase PCR. J Clin Microbiol 1997, 35(6):1348-1352. 229747, 9163442.
21. Kurabachew M, Wondimu A, Ryon JJ. Reverse transcription-PCR detection of Mycobacterium leprae in clinical specimens. J Clin Microbiol 1998, 36(5):1352-1356. 104827, 9574704.
22. Jiang WG, Davies G, Kynaston H, Mason MD, Fodstad O. Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?. Int J Mol Med 2006, 18(6):1169-1175.
23. Billiet L, Furman C, Larigauderie G, Copin C, Page S, Fruchart JC, Brand K, Rouis M. Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage. J Cell Physiol 2008, 214(1):183-191. 10.1002/jcp.21179, 17579352.
24. Sears DD, Hsiao A, Ofrecio JM, Chapman J, He W, Olefsky JM. Selective modulation of promoter recruitment and transcriptional activity of PPARgamma. Biochem Biophys Res Commun 2007, 364(3):515-521. 10.1016/j.bbrc.2007.10.057, 2585742, 17963725.
25. Ryckman C, McColl SR, Vandal K, de Medicis R, Lussier A, Poubelle PE, Tessier PA. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 2003, 48(8):2310-2320. 10.1002/art.11079, 12905486.
26. Fleischmann J, Golde DW, Weisbart RH, Gasson JC. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 1986, 68(3):708-711.
27. Borregaard N, Sorensen OE, Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007, 28(8):340-345. 10.1016/j.it.2007.06.002, 17627888.
28. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990, 343(6256):336-340. 10.1038/343336a0, 2137200.
29. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007, 219:88-102. 10.1111/j.1600-065X.2007.00550.x, 17850484.
30. Voit S, Udelhoven M, Lill G, Aktas B, Nieswandt B, Schror K, Weber AA. The C-terminal peptide of thrombospondin-1 stimulates distinct signaling pathways but induces an activation-independent agglutination of platelets and other cells. FEBS Lett 2003, 544(13):240-245. 10.1016/S0014-5793(03)00472-1, 12782324.
31. Thelwell C, Longstaff C. The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1. J Thromb Haemost 2007, 5(4):804-811. 10.1111/j.1538-7836.2007.02422.x, 17408411.
32. Koch J, Tampe R. The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation. Cell Mol Life Sci 2006, 63(6):653-662. 10.1007/s00018-005-5462-z, 16465444.
33. Bryant WM, Gibson MA, Shupnik MA. Stimulation of the novel estrogen receptor-alpha intronic TERP-1 promoter by estrogens, androgen, pituitary adenylate cyclase-activating peptide, and forskolin, and autoregulation by TERP-1 protein. Endocrinology 2006, 147(1):543-551. 10.1210/en.2005-1053, 16210360.
34. Marie I, Svab J, Robert N, Galabru J, Hovanessian AG. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J Biol Chem 1990, 265(30):18601-18607.
35. Accola MA, Huang B, Al Masri A, McNiven MA. The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum. J Biol Chem 2002, 277(24):21829-21835. 10.1074/jbc.M201641200, 11916975.
36. Wong JJ, Pung YF, Sze NS, Chin KC. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci USA 2006, 103(28):10735-10740. 10.1073/pnas.0600397103, 1484417, 16815975.
37. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 1991, 199(2):417-423. 10.1111/j.1432-1033.1991.tb16139.x, 1906403.
38. Nacu N, Luzina IG, Highsmith K, Lockatell V, Pochetuhen K, Cooper ZA, Gillmeister MP, Todd NW, Atamas SP. Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts. J Immunol 2008, 180(7):5036-5044. 2847349, 18354229.
39. Kivirikko S, Mauviel A, Pihlajaniemi T, Uitto J. Cytokine modulation of type XV collagen gene expression in human dermal fibroblast cultures. Exp Dermatol 1999, 8(5):407-412. 10.1111/j.1600-0625.1999.tb00390.x, 10536968.
40. Bertelli R, Valenti F, Oleggini R, Caridi G, Altieri P, Coviello DA, Botti G, Ravazzolo R, Ghiggeri GM. Cell-specific regulation of alpha1(III) and alpha2(V) collagen by TGF-beta1 in tubulointerstitial cell models. Nephrol Dial Transplant 1998, 13(3):573-579. 10.1093/ndt/13.3.573, 9550630.
41. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 2004, 23(9):1656-1667. 10.1038/sj.onc.1207064, 15001984.
42. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986, 261(9):4337-4345.
43. Pilette C, Ouadrhiri Y, Godding V, Vaerman JP, Sibille Y. Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J 2001, 18(3):571-588. 10.1183/09031936.01.00228801, 11589357.
44. Ochsenbein AF, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today 2000, 21(12):624-630. 10.1016/S0167-5699(00)01754-0, 11114423.
45. Quan CP, Berneman A, Pires R, Avrameas S, Bouvet JP. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997, 65(10):3997-4004. 175574, 9316998.
46. van Helden-Meeuwsen CG, Hazenberg MP. Background immunoglobulin-secreting cells specific for intestinal peptidoglycan-polysaccharides in mice. Immunobiology 1994, 190(3):295-301.
47. Butler JE. Isolator and other neonatal piglet models in developmental immunology and identification of virulence factors. Anim Health Res Rev 2009, 10(1):35-52. 10.1017/S1466252308001618, 19203413.
48. Butler JE, Sinkora M, Wertz N, Holtmeier W, Lemke CD. Development of the neonatal B and T cell repertoire in swine: implications for comparative and veterinary immunology. Vet Res 2006, 37(3):417-441. 10.1051/vetres:2006009, 16611556.
49. Gobet R, Cerny A, Ruedi E, Hengartner H, Zinkernagel RM. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. Exp Cell Biol 1988, 56(4):175-180.
50. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 1992, 358(6389):771-774. 10.1038/358771a0, 1324435.
51. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391(6662):82-86. 10.1038/34184, 9422509.
52. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391(6662):79-82. 10.1038/34178, 9422508.
53. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 2001, 7(1):161-171. 10.1016/S1097-2765(01)00164-2, 11172721.
54. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005, 122(5):707-721. 10.1016/j.cell.2005.06.029, 1430687, 16143103.
55. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447(7148):1116-1120. 10.1038/nature05894, 2587297, 17515919.
56. Edwards AM, Manetti AG, Falugi F, Zingaretti C, Capo S, Buccato S, Bensi G, Telford JL, Margarit I, Grandi G. Scavenger receptor gp340 aggregates group A streptococci by binding pili. Mol Microbiol 2008, 68(6):1378-1394. 10.1111/j.1365-2958.2008.06220.x, 18452511.
57. Cho JH, Fraser IP, Fukase K, Kusumoto S, Fujimoto Y, Stahl GL, Ezekowitz RA. Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity. Blood 2005, 106(7):2551-2558. 10.1182/blood-2005-02-0530, 1895263, 15956276.
58. Ulich TR, Guo K, Yin S, del Castillo J, Yi ES, Thompson RC, Eisenberg SP. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am J Pathol 1992, 141(1):61-68. 1886562, 1385928.
59. Mao XQ, Kawai M, Yamashita T, Enomoto T, Dake Y, Sasaki S, Kataoka Y, Fukuzumi T, Endo K, Sano H, Aoki T, Kurimoto F, Adra CN, Shirakawa T, Hopkin JM. Imbalance production between interleukin-1beta (IL-1beta) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma. Biochem Biophys Res Commun 2000, 276(2):607-612. 10.1006/bbrc.2000.3516, 11027520.
60. Chikanza IC, Roux-Lombard P, Dayer JM, Panayi GS. Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications. Arthritis Rheum 1995, 38(5):642-648. 10.1002/art.1780380511, 7748221.
61. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003, 300(2):472-476. 10.1016/S0006-291X(02)02841-3, 12504108.
62. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005, 174(9):5789-5795.
63. Qiu H, Gabrielsen A, Agardh HE, Wan M, Wetterholm A, Wong CH, Hedin U, Swedenborg J, Hansson GK, Samuelsson B, Paulsson-Berne G, Haeggstrom JZ. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA 2006, 103(21):8161-8166. 10.1073/pnas.0602414103, 1459628, 16698924.
64. Fu Y, Maianu L, Melbert BR, Garvey WT. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 2004, 32(1):182-190. 10.1016/j.bcmd.2003.09.002, 14757434.
65. Finkelstein RA, Sciortino CV, McIntosh MA. Role of iron in microbe-host interactions. Rev Infect Dis 1983, 5(Suppl 4):S759-77.
66. Brandenburg K, Jurgens G, Muller M, Fukuoka S, Koch MH. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol Chem 2001, 382(8):1215-1225. 10.1515/BC.2001.152, 11592403.
67. Qiu J, Hendrixson DR, Baker EN, Murphy TF, St Geme JW, Plaut AG. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci USA 1998, 95(21):12641-12646. 10.1073/pnas.95.21.12641, 22884, 9770539.
68. Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998, 95(16):9541-9546. 10.1073/pnas.95.16.9541, 21374, 9689116.
69. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R, Maccagno A, Riva F, Bottazzi B, Peri G, Doni A, Vago L, Botto M, De Santis R, Carminati P, Siracusa G, Altruda F, Vecchi A, Romani L, Mantovani A. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002, 420(6912):182-186. 10.1038/nature01195, 12432394.
70. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D, Skamene E, Olivier M, Jothy S, Gros P. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995, 182(3):655-666. 10.1084/jem.182.3.655, 2192162, 7650477.
71. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991, 174(4):915-924. 10.1084/jem.174.4.915, 2118975, 1655948.
72. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991, 146(10):3444-3451.
73. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30(10):475-487. 10.1016/j.it.2009.07.009, 19781994.
74. Payvandi F, Amrute S, Fitzgerald-Bocarsly P. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J Immunol 1998, 160(12):5861-5868.
75. Waibler Z, Anzaghe M, Konur A, Akira S, Muller W, Kalinke U. Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC. Eur J Immunol 2008, 38(11):3127-3137. 10.1002/eji.200838184, 18991289.
76. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:Article3.
77. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: a practical and powerful approach for multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 1995, 57(1):289-300.
78. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990, 215(3):403-410.
79. Beissbarth T, Speed TP. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 2004, 20(9):1464-1465. 10.1093/bioinformatics/bth088, 14962934.
80. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45.. 10.1093/nar/29.9.e45, 55695, 11328886.
81. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3(7):RESEARCH0034.. 10.1186/gb-2002-3-7-research0034, 126239, 12184808.
82. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30(9):e36. 10.1093/nar/30.9.e36, 113859, 11972351.